This dataset contains information on the decision by a pharmaceutical company to withdraw an application made to the European Medicines Agency for a human medicine.
It includes withdrawals of new marketing authorisation applications or for changes to existing marketing authorisations, which are evaluated by the Committee for Medicinal Products for Human Use (CHMP).
When an application is withdrawn after the first stage of evaluation by the CHMP, a withdrawal assessment report is published.
Search results can be exported in Excel format.
- Landing Page
- Data de publicação
- Data de alteração
European Medicines Agency
30 Churchill Place Canary Wharf London E14 5EU United Kingdom